Analyst Price Targets — CODX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 14, 2022 6:26 am | — | H.C. Wainwright | $180.00 | $109.50 | Benzinga | HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $6 |
| August 15, 2022 6:19 am | — | H.C. Wainwright | $270.00 | $134.40 | Benzinga | HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $9 |
| May 16, 2022 6:59 am | — | H.C. Wainwright | $360.00 | $136.50 | Benzinga | HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $12 |
Latest News for CODX
MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Department of State, and global stakeholders SALT LAKE CITY, April 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has been invited to participate in the…
Company to engage with global customers and distributors while expanding international commercial relationships SALT LAKE CITY, April 14, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will participate in the Congress of the European Society of Clinical…
Trade mission itinerary of business, government, and industry briefings across Switzerland and Germany to include site visits to Roche Diagnostics, UBS, Zurich Innovation Park and more SALT LAKE CITY, April 9, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced…
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript
Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures Progressing Clinical Pipeline and Regulatory Pathways for PCR Platform Strengthening Technology Leadership with AI Integration and Expanding IP Portfolio SALT LAKE CITY, March 31, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique,…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CODX.
U.S. House Trading
No House trades found for CODX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.